Chronic constipation is one of the most common disorders of the gut-brain interaction, affecting approximately one in ten adults worldwide. It has a substantial impact on quality of life and is associated with economic burdens, including direct costs and lost productivity1. Emerging evidence suggests that intestinal transit time is a key factor in shaping gut […]
1995: Making the connection with gut health. Although dietary oligosaccharides have long been used for health promotion, especially in Asia, it was not until 1995 that Glenn Gibson and Marcel Roberfroid expanded the definition of the prebiotic concept to include: “non-digestible food ingredients that beneficially affect the host by selectively stimulating the growth and/or activity […]
The gut microbiota plays a critical role in the pathogenesis of inflammatory bowel diseases (IBD), including both Crohn’s disease and ulcerative colitis, driving growing interest in therapies that target gut microbes as adjunctive or primary treatment. Among these, fecal microbiota transplantation (FMT) has attracted attention due to its remarkable success Clostridioides difficile infection1 and promising […]
About a third of patients with irritable bowel syndrome (IBS) develop disorderly eating habits and perceptions about food that can cause digestive symptoms and even an unhealthy preoccupation with healthy eating. In particular, many people believe with the condition Eating gluten or wheat is the most important culprit that causes their symptoms. This asks them […]
By 2030, one in six people will be 60 years or older worldwide1. It is also true that vulnerability is the result of aging and a decrease in muscle strength, cognitive changes and immunis function. Inflammation reactions and oxidative stress due to a changed intestinal microbiome can negatively influence muscle function and cognition. Although various […]